Showing results (261-270 of 323) with videos related to
Sort By:
Pageof 33
The British Journal of Surgery|March 3, 2016
Impact of multimodal therapy in locally recurrent rectal cancerY N You, J M Skibber, C-Y Hu, et al.Nature Genetics|September 6, 2000
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancerW M Grady, J Willis, P J Guilford, et al.Journal of Medical Genetics|June 14, 2000
Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general populationX P Zhou, W M Smith, O Gimm, et al.Proceedings of the National Academy of Sciences of the United States of America|December 26, 2001
Gene expression in papillary thyroid carcinoma reveals highly consistent profilesY Huang, M Prasad, W J Lemon, et al.Human Genetics|August 21, 2001
Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma casesW M Smith, X P Zhou, K Kurose, et al.Cancer Research|March 15, 1996
Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinomaD J Marsh, S D Andrew, C Eng, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 11, 2014
Clinicopathologic characteristics and gene expression analyses of non-KRAS 12/13, RAS-mutated metastatic colorectal cancerV K Morris, F A San Lucas, M J Overman, et al.Neuropathology and Applied Neurobiology|April 29, 1998
Analysis of the PTEN gene in human meningiomasN Peters, R Wellenreuther, B Rollbrocker, et al.Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancerE Mueller, M Smith, P Sarraf, et al.Human Molecular Genetics|July 7, 2001
Excessive CpG island hypermethylation in cancer cell lines versus primary human malignanciesD J Smiraglia, L J Rush, M C Frühwald, et al.Pageof 33